Cite

HARVARD Citation

    Kumar, P. et al. (n.d.). 1008. Disease Severity Impact on Long-Term Virologic Response to Ibalizumab in Expanded Access Protocol (TMB-311). Open forum infectious diseases. p. S532. [Online]. 
  
Back to record